The need for a holistic view on management of Clostridioides difficile infection

Author(s):
Wingen-Heimann, S.M.; Prehn, J. van (0000-0002-4544-4807); Kuijper, E.J.; Vehreschild, M.J.G.T.
Published
2021
Publication type
Other
BezlotoxumabClostridioides difficile infectionCost-effectivenessFidaxomicinPrevention of recurrent Clostridioides difficile infection
Date issued
2021-10-01
Language
English
Publisher
ELSEVIER SCI LTD
hdl
1887/3230194
doi
10.1016/j.cmi.2021.07.014
URL
http://www.clinicalmicrobiologyandinfection.com/article/S1198743X21004067/pdf